← Leaderboards
David H Munn
Medical College Of Georgia (Mcg)
$15,708,967
Attributed
$17,159,107
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,159,107 · 6
By mechanism
R01$17,159,107 · 6
Top collaborators
- Theodore S Johnson5 shared
Most similar at Medical College Of Georgia (Mcg)
Same institution · by research overlap
- Carlos Miguel Isales$12,455,426
- Andrew Lee Mellor$16,474,124
Others in their field
Top investigators on “Tryptophan 2,3 Dioxygenase”
- Bruce R. Blazar · University Of Minnesota$6,374,945
- Andrew Lee Mellor · Medical College Of Georgia (Mcg)$5,548,544
- L. Elliot Hong · University Of Maryland Baltimore$5,531,101
- Robert Dantzer · University Of Illinois Urbana-Champaign$5,197,486
- Syun-Ru Yeh · Yeshiva University$4,658,428
- Derek Alan Wainwright · University Of Chicago$4,487,916
Research focus
Tryptophan 2,3 DioxygenaseAntigensTumorPathway InteractionsResponseT-LymphocyteMediatingDendritic CellsImmune ResponseTumor AntigensRegulatory T-LymphocyteImmune SystemChemotherapyCellsImmunotherapyLinkInhibitor/AntagonistCd8b1 GeneSignal TransductionBasePharmaceutical PreparationsPhenotypeMolecularTryptophan
Grant awards (57)
Reprogramming the TME for immunogenic antigen-presentation$312,717
R01 · FY2024 · CA · contact PI
Chemo-radio immunotherapy for pediatric brain tumors$570,066
R01 · FY2023 · CA · contact PI
Reprogramming the TME for immunogenic antigen-presentation$329,175
R01 · FY2023 · CA · contact PI
Chemo-radio immunotherapy for pediatric brain tumors$570,066
R01 · FY2022 · CA · contact PI
Reprogramming the TME for immunogenic antigen-presentation$322,592
R01 · FY2022 · CA · contact PI
Chemo-radio immunotherapy for pediatric brain tumors$581,700
R01 · FY2021 · CA · contact PI
PTEN, Tregs and MDSCs in the tumor microenvironment$347,700
R01 · FY2021 · CA · contact PI
Reprogramming the TME for immunogenic antigen-presentation$329,175
R01 · FY2021 · CA · contact PI
Chemo-radio immunotherapy for pediatric brain tumors$581,700
R01 · FY2020 · CA · contact PI
PTEN, Tregs and MDSCs in the tumor microenvironment$347,700
R01 · FY2020 · CA · contact PI
Reprogramming the TME for immunogenic antigen-presentation$328,641
R01 · FY2020 · CA · contact PI
Chemo-radio immunotherapy for pediatric brain tumors$596,748
R01 · FY2019 · CA · contact PI
PTEN, Tregs and MDSCs in the tumor microenvironment$337,268
R01 · FY2019 · CA · contact PI
PTEN, Tregs and MDSCs in the tumor microenvironment$347,700
R01 · FY2018 · CA · contact PI
IDO-Expressing Immunoregulatory Dendritic Cells$307,800
R01 · FY2018 · CA · contact PI
PTEN, Tregs and MDSCs in the tumor microenvironment$347,700
R01 · FY2017 · CA · contact PI
IDO-Expressing Immunoregulatory Dendritic Cells$307,800
R01 · FY2017 · CA · contact PI
IDO-Expressing Immunoregulatory Dendritic Cells$307,800
R01 · FY2016 · CA · contact PI
Role of IDO in malignancy$240,933
R01 · FY2016 · CA · contact PI
IDO-Expressing Immunoregulatory Dendritic Cells$307,631
R01 · FY2015 · CA · contact PI
Role of IDO in malignancy$240,933
R01 · FY2015 · CA · contact PI
IDO-Expressing Immunoregulatory Dendritic Cells$305,607
R01 · FY2014 · CA · contact PI
IDO-mediated immune regulation in established tumors$240,103
R01 · FY2014 · CA · contact PI
Role of IDO in malignancy$233,705
R01 · FY2014 · CA · contact PI
IDO-expressing immunoregulatory dendritic cells$262,129
R01 · FY2013 · CA · contact PI
IDO-mediated immune regulation in established tumors$232,677
R01 · FY2013 · CA · contact PI
Role of IDO in malignancy$226,477
R01 · FY2013 · CA · contact PI
IDO-expressing immunoregulatory dendritic cells$278,861
R01 · FY2012 · CA · contact PI
IDO-mediated immune regulation in established tumors$247,529
R01 · FY2012 · CA · contact PI
Role of IDO in malignancy$240,933
R01 · FY2012 · CA · contact PI
IDO-expressing immunoregulatory dendritic cells$278,861
R01 · FY2011 · CA · contact PI
IDO-mediated immune regulation in established tumors$247,529
R01 · FY2011 · CA · contact PI
Role of IDO malignancy$236,114
R01 · FY2011 · CA · contact PI
IDO-expressing immunoregulatory dendritic cells$287,486
R01 · FY2010 · CA · contact PI
IDO-mediated immune regulation in established tumors$255,185
R01 · FY2010 · CA · contact PI
Role of IDO malignancy$243,417
R01 · FY2010 · CA · contact PI
IDO-expressing immunoregulatory dendritic cells$287,486
R01 · FY2009 · CA · contact PI
Role of IDO malignancy$243,417
R01 · FY2009 · CA · contact PI
IDO-expressing plasmacytoid dendritic cells and tumors$241,011
R01 · FY2009 · CA · contact PI
Role of IDO malignancy$243,417
R01 · FY2008 · CA · contact PI
IDO-expressing plasmacytoid dendritic cells and tumors$241,011
R01 · FY2008 · CA · contact PI
IDO-expressing immunoregulatory dendritic cells$271,519
R01 · FY2007 · CA · contact PI
Role of IDO malignancy$243,417
R01 · FY2007 · CA · contact PI
IDO-expressing plasmacytoid dendritic cells and tumors$241,011
R01 · FY2007 · CA · contact PI
IDO-expressing immunoregulatory dendritic cells$279,628
R01 · FY2006 · CA · contact PI
IDO-expressing plasmacytoid dendritic cells and tumors$248,209
R01 · FY2006 · CA · contact PI
Role of IDO in Malignancy$232,151
R01 · FY2006 · CA · contact PI
IDO-expressing immunoregulatory dendritic cells$286,358
R01 · FY2005 · CA
IDO-expressing plasmacytoid dendritic cells and tumors$254,183
R01 · FY2005 · CA
Role of IDO in Malignancy$237,738
R01 · FY2005 · CA
IDO-expressing immunoregulatory dendritic cells$286,358
R01 · FY2004 · CA
Role of IDO in Malignancy$237,738
R01 · FY2004 · CA
IDO-expressing immunoregulatory dendritic cells$286,358
R01 · FY2003 · CA
Role of IDO in Malignancy$237,738
R01 · FY2003 · CA
MACROPHAGE MEDIATED IMMUNOREGULATION VIA TRYPTOPHAN$266,965
R01 · FY2002 · HL
MACROPHAGE MEDIATED IMMUNOREGULATION VIA TRYPTOPHAN$259,508
R01 · FY2001 · HL
MACROPHAGE MEDIATED IMMUNOREGULATION VIA TRYPTOPHAN$253,728
R01 · FY2000 · HL